Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Pharmacogenomics|December 5, 2009
Development of an undergraduate pharmacogenomics curriculumTravis J O'Brien, Federico Goodsaid, Margaret Plack, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2013
The current status of biomarkers for predicting toxicitySarah Campion, Jiri Aubrecht, Kim Boekelheide, et al.
NPJ Genomic Medicine|January 23, 2018
A robust targeted sequencing approach for low input and variable quality DNA from clinical samplesAustin P So, Anna Vilborg, Yosr Bouhlal, et al.
Nature Reviews. Drug Discovery|November 1, 2011
Quantifying factors for the success of stratified medicineMark R Trusheim, Breon Burgess, Sean Xinghua Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2014
Turning the tide against cancer through sustained medical innovation: the pathway to progressAmy Abernethy, Edward Abrahams, Anna Barker, et al.
Omics : a Journal of Integrative Biology|May 2, 2008
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?"Susanna-Assunta Sansone, Philippe Rocca-Serra, Marco Brandizi, et al.
Plos One|September 13, 2012
Technical reproducibility of genotyping SNP arrays used in genome-wide association studiesHuixiao Hong, Lei Xu, Jie Liu, et al.
Nature Biotechnology|May 12, 2010
Towards consensus practices to qualify safety biomarkers for use in early drug developmentFrank D Sistare, Frank Dieterle, Sean Troth, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2020
A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cellsDrake M Mellott, Chien-Te Tseng, Aleksandra Drelich, et al.
ACS Chemical Biology|March 31, 2021
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey CellsDrake M Mellott, Chien-Te Tseng, Aleksandra Drelich, et al.
Pageof 4